The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

23 articles for JA Ellman


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease.EBI
University of California
Synthesis of benzopentathiepin analogs and their evaluation as inhibitors of the phosphatase STEP.EBI
Yale University
Novel inhibitors of alpha 4 beta 1 integrin receptor interactions through library synthesis and screening.EBI
University of California
Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase.EBI
Yale University
Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.EBI
University of California
Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy.EBI
University of California
Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors.EBI
Yale University
General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.EBI
University of California
Design and synthesis of novel inhibitors of gelatinase B.EBI
University of California
Tyrosylprotein sulfotransferase inhibitors generated by combinatorial target-guided ligand assembly.EBI
University of California
Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis.EBI
University of California
Optimization of a somatostatin mimetic via constrained amino acid and backbone incorporation.EBI
University of California
Cellular Activity of New Small Molecule Protein Arginine Deiminase 3 (PAD3) Inhibitors.EBI
Yale University
Compounds that activate the mouse melanocortin-1 receptor identified by screening a small molecule library based upon the beta-turn.EBI
Oregon Health Sciences University
Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.EBI
University of California
Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.EBI
Yale University
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.EBI
Yale University
Substituted pyridine derivatives useful as C-FMS kinase inhibitorsBDB
Janssen Pharmaceutica
2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action.BDB
Aristotle University
Discovery of novel heterocyclic factor VIIa inhibitors.BDB
Celera
Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1.BDB
Korea Research Institute of Bioscience and Biotechnology
Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases.BDB
Institut Curie